$0.970000
0.055.43%
Pre-Market: 5:11 PM EDT
Comments
Loading...
NeuroSense Therapeutics (NASDAQ:NRSN) Stock, Earnings Estimates, EPS, And Revenue
NeuroSense Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Dec 3
EPS Estimate
$-0.210
Quarterly Revenue Estimate
–
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of NeuroSense Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
NeuroSense Therapeutics (NRSN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-09-30 | $-0.02 | $-0.20 | 90.0 % |
| Mar 2024 | 2024-06-24 | $-0.35 | $-0.20 | -75.0 % |
| Mar 2024 | 2024-04-05 | $-0.16 | $-0.23 | 30.4 % |
NeuroSense Therapeutics (NRSN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is NeuroSense Therapeutics (NASDAQ:NRSN) reporting earnings?
NeuroSense Therapeutics (NRSN) is scheduled to report earnings on December 3, 2024. The last reported earnings were for reported on September 30, 2024 for Q2.
What were the latest earnings per share (EPS) for NeuroSense Therapeutics (NASDAQ:NRSN)?
The Actual EPS was $-0.02, which beat the estimate of $-0.20.
What were NeuroSense Therapeutics’s (NASDAQ:NRSN) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.